Halozyme Therapeutics Inc (HALO)
63.70
-0.78
(-1.21%)
USD |
NASDAQ |
Mar 28, 15:23
Halozyme Therapeutics Total Liabilities (Quarterly): 1.700B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.331B |
| Johnson & Johnson | 108.61B |
| Catalyst Pharmaceuticals Inc | 123.78M |
| Merck & Co Inc | 70.73B |
| AIM ImmunoTech Inc | 10.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.063B |
| Shareholders Equity (Quarterly) | 363.82M |
| Debt to Equity Ratio | 4.139 |
| Current Ratio | 7.803 |
| Net Debt Paydown Yield | -0.03% |